Compare EVO & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | INDI |
|---|---|---|
| Founded | 1993 | 2007 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.5M | 906.0M |
| IPO Year | N/A | 2021 |
| Metric | EVO | INDI |
|---|---|---|
| Price | $2.72 | $3.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $7.00 | $6.25 |
| AVG Volume (30 Days) | 28.7K | ★ 5.8M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $217,394,000.00 |
| Revenue This Year | $1.37 | $25.54 |
| Revenue Next Year | $10.05 | $38.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.33 |
| 52 Week Low | $2.31 | $2.32 |
| 52 Week High | $4.42 | $6.05 |
| Indicator | EVO | INDI |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 43.87 |
| Support Level | $2.63 | $3.47 |
| Resistance Level | $3.82 | $4.11 |
| Average True Range (ATR) | 0.07 | 0.42 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 27.55 | 12.61 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.